This is a study to determine the effects of adding liraglutide to an existing treatment of rosiglitazone (Avandia) and metformin, and then to compare the three-drug combination to therapy with rosiglitazone and metformin alone. This international study is currently recruiting patients with Type 2 diabetes.
Read moreThe drug metformin is not recommended for people with kidney disease. For this reason, some people think that metformin causes kidney... Read more »
I received an interesting question by e-mail recently, which brought up several good points to review. The author asked: "Can a patient... Read more »
A recent report again reaffirms that metformin is the first medication to use when a patient with type 2 diabetes (T2D) needs help with... Read more »
Metformin as well as every other prescription drug has a "label" (in the US, called a "United States package insert" or USPI, and in Europe... Read more »
Metformin controls the insulin resistance of people who have type 2 diabetes so well that, if possible, all of us should be taking it.... Read more »
This is a study to compare the safety and effectiveness of a combination of prandial inhaled insulin and metformin with the inhaled insulin and a... Read more »
Metformin may lower diabetics' risk of pancreatic cancer by up to 60 percent, a new study suggests. Read more »
U.S. researchers say the diabetes drug Metformin is safe for patients with advanced heart failure. In a study of 401 diabetic patients with the... Read more »
The diabetes drug metformin has shown success in treating breast cancer when paired with common chemotherapy drugs, a mouse study suggests.... Read more »
The diabetes drug metformin may help obese teenagers lose weight--even if they don't have diabetes. The two-year study of 77 volunteers found that... Read more »